Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881278 · ClinicalTrials.gov registry record · NA
XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
A NA study of Heart Failure and Transplant; Failure, Heart, sponsored by XVIVO Perfusion.
- Active
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 20
- Study locations
NCT05881278 is a NA study of Heart Failure and Transplant; Failure, Heart that is active but no longer recruiting, run by XVIVO Perfusion. The registered enrollment target is 141 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT05881278, a NA study of Heart Failure and Transplant; Failure, Heart, is active but no longer recruiting, sponsored by XVIVO Perfusion.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Conditions Studied
Interventions
- DEVICE Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS)
Study Locations (20)
California
- University of California San Diego - La Jolla
- Cedars-Sinai - Los Angeles
- David Geffen School of Medicine at UCLA - Los Angeles
- Stanford Medicine - Palo Alto
New York
- NYU Langone Health - New York
- Columbia University Irving Medical Center/New York Presbyterian Hospital - New York
- Montefiore Medical Center - The Bronx
Maryland
- University of Maryland Medical Center/University of Maryland, Baltimore - Baltimore
- Johns Hopkins Medicine - Baltimore
Ohio
- Cleveland Clinic Foundation - Cleveland
- Ohio State University - Columbus
Georgia
- Emory University - Atlanta
Illinois
- Northwestern Memorial Hospital - Chicago
Missouri
- Washington University - Barnes Jewish Hospital - St Louis
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2029-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05881278
The ClinicalTrials.gov registry entry for NCT05881278 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (93% lower). The listed sponsor is XVIVO Perfusion, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS) is the first listed.
NCT05881278 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, New York, Maryland.
Frequently Asked Questions
What is clinical trial NCT05881278 about?
NCT05881278 is a clinical study titled "XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)". The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
What is the current status of trial NCT05881278?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 141 participants. The study started on 2023-10-10. Estimated completion is 2029-11.
What conditions does trial NCT05881278 study?
This clinical trial studies the following conditions: Heart Failure, Transplant; Failure, Heart.
What interventions are being tested in trial NCT05881278?
The interventions under investigation include: Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS) (DEVICE).
Who is sponsoring clinical trial NCT05881278?
This trial is sponsored by XVIVO Perfusion, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05881278 being conducted?
This trial has 20 study locations across California, Georgia, Illinois, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.